MONSTER BEVERAGE CORP (MNST)
US61174X1090 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to MNST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.6. This target is 16.09% above the current price.
MNST was analyzed by 30 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MNST.
In the previous month the buy percentage consensus was at a similar level.
MNST was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-20 | Roth MKM | Maintains | Neutral -> Neutral |
| 2023-11-20 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-11-13 | Jefferies | Initiate | Buy |
| 2023-10-31 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-24 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-10-17 | B of A Securities | Maintains | Buy -> Buy |
| 2023-10-11 | Citigroup | Maintains | Buy -> Buy |
| 2023-08-14 | HSBC | Initiate | Buy |
| 2023-08-10 | MKM Partners | Maintains | Neutral -> Neutral |
| 2023-08-10 | Evercore ISI Group | Reiterate | Outperform -> Outperform |
| 2023-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-08-07 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-08-04 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-07-31 | Stifel | Maintains | Buy -> Buy |
| 2023-07-25 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-06-08 | Piper Sandler | Initiate | Neutral |
| 2023-05-08 | Roth MKM | Maintains | Neutral |
| 2023-05-08 | Morgan Stanley | Maintains | Overweight |
| 2023-05-05 | RBC Capital | Maintains | Outperform |
| 2023-05-05 | Wells Fargo | Maintains | Overweight |
| 2023-05-05 | Truist Securities | Maintains | Buy |
| 2023-05-05 | Goldman Sachs | Maintains | Buy |
| 2023-05-05 | Citigroup | Maintains | Buy |
| 2023-05-02 | Deutsche Bank | Maintains | Buy |
| 2023-04-06 | UBS | Maintains | Neutral |
| 2023-04-03 | Stifel | Maintains | Buy |
| 2023-03-30 | Wedbush | Maintains | Neutral |
| 2023-03-28 | Morgan Stanley | Maintains | Overweight |
| 2023-03-21 | Argus Research | Maintains | Buy |
| 2023-03-06 | Redburn Partners | Upgrade | Neutral -> Buy |